Abstract

Numerous membrane-bound proteins undergo regulated intramembrane proteolysis. Regulated intramembrane proteolysis is initiated by shedding, and the remaining stubs are further processed by intramembrane-cleaving proteases (I-CLiPs). Neuregulin 1 type III (NRG1 type III) is a major physiological substrate of β-secretase (β-site amyloid precursor protein-cleaving enzyme 1 (BACE1)). BACE1-mediated cleavage is required to allow signaling of NRG1 type III. Because of the hairpin nature of NRG1 type III, two membrane-bound stubs with a type 1 and a type 2 orientation are generated by proteolytic processing. We demonstrate that these stubs are substrates for three I-CLiPs. The type 1-oriented stub is further cleaved by γ-secretase at an ϵ-like site five amino acids N-terminal to the C-terminal membrane anchor and at a γ-like site in the middle of the transmembrane domain. The ϵ-cleavage site is only one amino acid N-terminal to a Val/Leu substitution associated with schizophrenia. The mutation reduces generation of the NRG1 type III β-peptide as well as reverses signaling. Moreover, it affects the cleavage precision of γ-secretase at the γ-site similar to certain Alzheimer disease-associated mutations within the amyloid precursor protein. The type 2-oriented membrane-retained stub of NRG1 type III is further processed by signal peptide peptidase-like proteases SPPL2a and SPPL2b. Expression of catalytically inactive aspartate mutations as well as treatment with 2,2'-(2-oxo-1,3-propanediyl)bis[(phenylmethoxy)carbonyl]-l-leucyl-l-leucinamide ketone inhibits formation of N-terminal intracellular domains and the corresponding secreted C-peptide. Thus, NRG1 type III is the first protein substrate that is not only cleaved by multiple sheddases but is also processed by three different I-CLiPs.

Highlights

  • Intramembrane proteolysis by ␥-secretase occurs via multiple cleavages starting at an ⑀-site close to the C-terminal end of the transmembrane domains (TMDs) and ending after an intermediate cut at a ␨-site at the ␥-site in the middle of the TMD (8 –10). ␥-Secretase processes numerous membrane-retained type 1-oriented C-terminal stubs [11]. ␥-Secretase cleavage liberates intracellular domains (ICD), which can be involved in reverse signaling as well as small secreted peptides such as amyloid ␤-peptide (A␤) [6]

  • This revealed that the cleavage sites were very similar, the ratio of the individual cleavages shifted slightly so that cleavage after leucine 315 became more prominent (Fig. 4, A and B). Such minor changes in the quantitative but not qualitative cleavage pattern are probably due to slight differences in substrate positioning at the active site of ␥-secretase or antibodies used for immunoprecipitation and have been described before for a truncated Notch1 substrate [39, 46]. These results suggest that the NRG1 type III ICD is released into the cytosol through intramembrane cleavage at an ⑀-like site located in close proximity to the cytosolic membrane border, whereas the ␥-cleavage, which releases NRG1-␤, occurs within the middle of the TMD (Fig. 4C)

  • The remaining NTF is apparently further trimmed by a so far unknown sheddase, which generates the 28-kDa NTFЈ in Figs. 1A and 7A. This is the first example of a regulated intramembrane proteolysis substrate, which requires dual shedding to allow subsequent cleavage by intramembrane-cleaving proteases (I-CLiPs)

Read more

Summary

The abbreviations used are

I-CLiP, intramembrane-cleaving protease; ADAM, a disintegrin and metalloprotease; A␤; amyloid ␤-peptide; APP, ␤-amyloid precursor protein; BACE1, ␤-site APP-cleaving enzyme 1; CTF, C-terminal fragment; ICD, intracellular domain; NRG1, neuregulin 1; NTF, N-terminal fragment; PS, presenilin; SPP, signal peptide peptidase; SPPL, SPP-like; SNP, single nucleotide polymorphism; TMD, transmembrane domain; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; GV, Gal4-VP16; IP, immunoprecipitation; (Z-LL)2, 2,2Ј-(2-oxo-1,3-propanediyl)bis[(phenylmethoxy)carbonyl]-L-leucyl-L-leucinamide; DAPT, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester; IAA, iodoacetic acid. Shedding of NRG1 type III is initiated by BACE1 or ADAM10/17 (Fig. 1A) This cleavage exposes the epidermal growth factor (EGF)-like domain to allow ErbB3 signaling, which is required for myelination of the peripheral nervous system during early postnatal development. We identified the corresponding cleavage sites and could show that the valine to leucine exchange, which is associated with schizophrenia, is only one amino acid C-terminal to the initial cleavage site of ␥-secretase This mutation reduces generation of the NRG1 type III ␤-peptide (NRG1-␤) and signaling via the ICD and affects the cleavage precision of ␥-secretase

Experimental Procedures
Results
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call